Overview
The SensoLyte® 520 Rat Renin Assay Kit is designed for researchers looking to quantify renin activity and identify potential inhibitors effectively. This fluorimetric assay leverages the 5-FAM/QXL™520 FRET technology for a highly sensitive detection of renin, a key enzyme involved in blood pressure regulation. By cleaving angiotensinogen to produce angiotensin I, which is converted to angiotensin II by ACE (Angiotensin Converting Enzyme), understanding renin’s role is crucial for developing therapies aimed at managing hypertension.
Key Features
- Fluorimetric assay suitable for high throughput screening
- Utilizes 5-FAM/QXL™520 FRET for enhanced sensitivity
- Ideal for studying renin’s role in cardiovascular health
- Compatible with various laboratory setups
- Comprehensive kit for continuous monitoring of renin activity
Specifications
| Product Name | SensoLyte® 520 Rat Renin Assay Kit |
| Type | Fluorimetric Assay |
| Applications | Renin activity and inhibitor screening |
| Compatibility | High throughput systems |
| Quantity | 1 kit |
FAQ
What is the main application of the SensoLyte® 520 Rat Renin Assay Kit?
This kit is primarily used to evaluate renin activity and screen for potential renin inhibitors, which can help in hypertension research and therapy development.
How does this assay work?
The assay utilizes fluorimetric detection through FRET technology, enabling precise measurements of renin activity based on substrate cleavage resulting in fluorescent signals.
Can this kit be used for high throughput screening?
Yes, the SensoLyte® 520 Rat Renin Assay Kit is specifically designed for high throughput applications, making it efficient for large-scale studies.
Alongside other essential tools in our assay kits category, this kit enriches your laboratory’s ability to conduct impactful research. Explore further assays such as the SensoLyte® Anti-Human MOG ELISA Kit or the SensoLyte® Anti-PLP ELISA Kit to complement your studies into autoimmune and cardiovascular health.




Reviews
There are no reviews yet.